Podcast thumbnail for Outperform Cancer

Outperform Cancer

Claim This Podcast

by Marybeth Gilliam

17 episodes
Updated Bi-weekly
Accepts GuestsHas Sponsors
44

Podcast Authority

Beta
FairBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality49
Social0
YouTube68
Engagement32

Podcast Overview

<p>Actionable, anti-cancer strategies found in peer-reviewed, scientific research to improve cancer outcomes.</p>

Language

🇺🇲

Publishing Since

9/27/2023

Unlock The Full Podcast Authority Score Report

See how your podcast performs across key metrics

44

Podcast Authority

Beta
FairBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality49
Social0
YouTube68
Engagement32
8
Excellent Areas
0
Good Performance
11
Growth Opportunities
excellent
Episode Length
51 minutes
Performing excellently!
poor
Publishing Consistency
Every 56 days

Recommendations available

Unlock the full report to see detailed tips

+16 More Metrics

Unlock comprehensive insights including:

  • • YouTube presence analysis
  • • Social media reach metrics
  • • RSS compliance scoring
  • • Podcast 2.0 features
  • • Technical standards
What's Included in Your Full Report

Detailed Analytics

  • Complete breakdown of all 19 authority metrics
  • Personalized recommendations for each metric
  • Industry benchmarks and comparisons
  • Technical RSS feed analysis and compliance scoring

Growth Strategies

  • Step-by-step action plans for improvement
  • Quick wins to boost your score immediately
  • Pro tips from successful podcasters
Get your free podcast insights report

See how your show performs across every key metric

Instant delivery
No spam
Attract Better Guests

High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.

Secure Sponsorships

Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.

Grow Your Audience

Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.

1 verified contact email on file for Outperform Cancer

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for Mammograms Save Lives—So Why Are Women Still Diagnosed With Late-Stage Breast Cancer?

June 18, 2026

Mammograms Save Lives—So Why Are Women Still Diagnosed With Late-Stage Breast Cancer?

In this episode of Outperform Cancer, Marybeth Gilliam speaks with Dr. Ryan Polselli, a fellowship-trained breast imaging radiologist and founder and CEO of MammoLink, about one of the most important questions in breast cancer care: if mammograms save lives, why are women still being diagnosed with late-stage breast cancer? Dr. Polselli explains that the problem is not simply whether mammograms work — it is whether the screening system is working for patients. Too many women are not getting screened annually, dense breast tissue can make cancer harder to detect, genetic risk is often identified only after diagnosis, and unnecessary friction in the healthcare system causes patients to delay or skip screening altogether. The conversation explores how breast cancer detection can become more personalized through annual screening, risk assessment, genetic testing, breast density awareness, AI-supported imaging, same-day ultrasound when appropriate, and better access through mobile mammography. Dr. Polselli also discusses how MammoLink is working to remove barriers by bringing breast imaging directly to workplaces and communities, making screening easier, faster, and more patient-centered. Marybeth also shares her own experience of being diagnosed after insisting on further testing despite a “clear” mammogram, reinforcing one of the episode’s most important messages: women should trust their bodies, understand their risk, and advocate for additional imaging or biopsy when something does not feel right. This episode is a call to rethink breast cancer screening as a strategy — one that uses the tools we already have more effectively to catch cancer earlier, reduce late-stage diagnoses, and help more women get the care they need before it is too late.

Episode thumbnail for A New Operating System for Cancer: How Sid Sijbrandij is Outpacing an Evolving Disease

June 2, 2026

A New Operating System for Cancer: How Sid Sijbrandij is Outpacing an Evolving Disease

What do you do when you’re told: “There’s nothing more we can do”? That’s the moment Sid Sijbrandij faced after exhausting standard of care for osteosarcoma. Instead of accepting it, he did something radically different. He went “Founder Mode” on his cancer—applying the same mindset he used to build GitLab to create a completely new way of approaching treatment. What emerged isn’t just a set of therapies. It’s a new operating system for cancer—one built on: maximal diagnostics continuous data collection testing treatments in parallel and learning faster than the disease evolves In this episode, we break that system down—not just as Sid’s story, but as a framework patients can start using today. This conversation is not about doing everything Sid has done. It’s about learning how to think differently—so you can ask better questions, access better options, and make more informed decisions about your care. Because cancer isn’t one problem. It’s a system. And when you start treating it that way, everything changes.

Episode thumbnail for Can Broccoli Sprouts Fight Cancer? What 30 Years of Research Shows

May 14, 2026

Can Broccoli Sprouts Fight Cancer? What 30 Years of Research Shows

What if one of the most studied anti-cancer compounds isn’t a drug—but a compound found in broccoli sprouts? In this episode, Jed Fahey, a nutritional biochemist and one of the world’s leading experts on sulforaphane, breaks down over 30 years of research on this powerful compound and its potential role in cancer prevention and treatment. Recent research has taken this conversation to another level. A 2024 review in the journal Cancer found that sulforaphane demonstrates “potent chemosensitizing capabilities across diverse cancer types,” meaning it may help make cancer cells more responsive to chemotherapy while counteracting treatment resistance. In this conversation, we explore: - How sulforaphane works at the molecular level, including its effects on detoxification pathways like NRF2 - Why broccoli sprouts contain dramatically higher levels than mature broccoli - The difference between supplements and whole foods—and what patients should consider - The emerging science around cancer stem cells, metastasis, and recurrence - How sulforaphane may work synergistically with cancer therapies This is not about replacing standard treatment. It’s about understanding how simple, science-backed strategies—like broccoli sprouts—may play a meaningful role alongside it. If you’re looking for actionable, research-driven ways to support your body, this episode translates complex cancer biology into clear, practical insights you can use today.

17 total episodes available

Recent guests on Outperform Cancer

Guests from recent episodes — sign up to see every guest that has ever appeared on this show.

Kristen Dahlgren

Guest

Deep-dive analytics for Outperform Cancer

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Outperform Cancer?
<p>Actionable, anti-cancer strategies found in peer-reviewed, scientific research to improve cancer outcomes.</p>
How often does this podcast release new episodes?

This podcast updates bi-weekly.

Where can I listen to this podcast?

This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.